JRCT ID: jRCT2080221142
Registered date:30/06/2010
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Post-Herpetic Neuralgia |
Date of first enrollment | 30/06/2010 |
Target sample size | 160 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : JTS-653 INN of investigational material : Therapeutic category code : 129 Other agents affecting peripheral nervous system Dosage and Administration for Investigational material : Oral control material(s) Generic name etc : Placebo INN of investigational material : Therapeutic category code : --- Other Dosage and Administration for Investigational material : Oral |
Outcome(s)
Primary Outcome | Visual analog scale |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | The patient who passed for 3 months or more after the herpes zoster onset. |
Exclude criteria | The patient who has other chronic pains in the PHN affected part |
Related Information
Primary Sponsor | JAPAN TABACCO INC. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-101177 |
Contact
Public contact | |
Name | |
Address | clinicaltrials.info@jt.com |
Telephone | |
Affiliation | Japan Tobacco Inc. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |